Drug maker Lupin on Monday said its subsidiary has inked a pact to fully acquire Amsterdam-headquartered VISUfarma BV at an enterprise value of 190 million euros. The company’s wholly-owned subsidiary ...
Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 24,000 professionals. Lupin is committed to improving patient health ...
Mumbai-based pharmaceutical major Lupin will acquire Netherlands-based VISUfarma B.V. for an enterprise value of EUR 190 million (about Rs 2,000 crore) through its wholly owned subsidiary Nanomi B.V., ...
LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG ...
London, Mumbai, 29 September, 2025: Global Healthcare Opportunities, or GHO Capital Partners LLP ("GHO”), the European specialist investor in global healthcare, is delighted to announce the sale of ...
Hosted on MSN

Living Local S1E1 - MSN

Lewis Hamilton Says He's Sold His Entire Car Collection: 'I'm More Into Art Nowadays' Noah Wyle Finally Won an Emmy—and Knew Exactly Who to Dedicate It To Kennedy's Vaccine Advisers Decline To ...
While Indian markets opened on a slightly positive note Wednesday, Lupin Ltd stock led the Nifty Midcap 150 losers, trading at Rs 2,027.30, a 1.19% drop from the previous close. Ola Electric and Tube ...
New Delhi: In a move to address India's obesity crisis, two major pharmaceutical companies—Sun Pharma Laboratories Ltd and Lupin Ltd—are working to create an affordable anti-obesity pill, according to ...
Lupin Limited announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Risperidone for extended-release injectable ...
Lupin has received approval from the Food and Drug Administration for loteprednol etabonate ophthalmic gel, 0.38%, which is the generic of Bausch & Lomb’s Lotemax SM Ophthalmic Gel. Lupin is the ...
The hit Netflix series starring Omar Sy is back and already in production in Paris. By Tony Maglio We don’t have to say au revoir to Lupin, merci. Part four of the hit series is already in production ...